Kirk Morris
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 16
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 6
- Chronic Myeloid Leukemia Treatments 4
- Oncology 13
- Cancer Risks and Factors 5
- Neutropenia and Cancer Infections 4
- Co-authors
- Glen Kennedy (17 shared papers)Peter Mollee (9 shared papers)Paula Marlton (7 shared papers)A. J. Beddall (1 shared paper)Saad Al‐Ismail (1 shared paper)Roger Munro (1 shared paper)Joseph R. Casey (1 shared paper)Kathryn Jackson (7 shared papers)
- Journals
- Blood (8 papers)British Journal of Haematology (2 papers)Transfusion (1 paper)Advances in Radiation Oncology (1 paper)International Journal of Hematology (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Kirk Morris
30 papers receiving 247 citations
Peers
Comparison fields: 5 of 79
- Hematology 84
- Genetics 44
- Oncology 77
- Emergency Medicine 16
- Epidemiology 51
Countries citing papers authored by Kirk Morris
This map shows the geographic impact of Kirk Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Morris more than expected).
Fields of papers citing papers by Kirk Morris
This network shows the impact of papers produced by Kirk Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Morris. The network helps show where Kirk Morris may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirk Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 53 | |
| 2 | 2013 | 34 | |
| 3 | 2013 | 25 | |
| 4 | Trade Flows and Marketing Practices within the United States Nursery Industry: 2003 | 2005 | 22 |
| 5 | 2010 | 20 | |
| 6 | 2007 | 20 | |
| 7 | 2004 | 8 | |
| 8 | 2004 | 7 | |
| 9 | 2017 | 7 | |
| 10 | 2015 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2013 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2011 | 5 | |
| 16 | 2016 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2024 | 1 | |
| 20 | Survival and prognostic factors amongst Australian patients with AL amyloidosis | 2010 | 1 |
About Kirk Morris
Kirk Morris is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 255 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Cancer Risks and Factors (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Neutropenia and Cancer Infections (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (84 citations), Genetics (44 citations), Oncology (77 citations), Emergency Medicine (16 citations) and Epidemiology (51 citations). Kirk Morris has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Glen Kennedy, Peter Mollee, Paula Marlton, A. J. Beddall, Saad Al‐Ismail, Roger Munro, Joseph R. Casey, Kathryn Jackson, Devinder Gill and Jason Butler. Their work appears in journals such as Blood, British Journal of Haematology, Transfusion, Advances in Radiation Oncology and International Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.